Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate, by way of randomized controlled trial, the effectiveness of a web-based, time-flexible, and teacher-directed "Teacher Help for ADHD" program in reducing the impact of ADHD symptoms in elementary students.


Clinical Trial Description

*Please note that the information below is taken verbatim from our project's research summary.*

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most well-researched areas in childhood psychopathology. ADHD is a highly prevalent (5% of school-aged children) and chronic disorder (ADHD will persist into adulthood for ~70% of children diagnosed with this disorder). ADHD has a substantial impact on daily life including difficulties with behavioural, academic, social and emotional functioning (DuPaul & Weyandt, 2006).

Although medication is the most commonly used treatment, there are a number of important limitations including poor long-term effects, lack of effectiveness in improving academic skills, and lack of acceptability by parents and children (DuPaul, 2007). Therefore, a number of psychosocial interventions have been developed and empirically validated (parent training, social skills training, school-based interventions). School-based interventions have been shown to be effective; however, these are significantly underutilized and when implemented in an uncontrolled way, are often ineffective. This intervention program is comprised of evidence-based treatment strategies that are presented in a manner that will provide teachers with knowledge of the disorder and intervention strategies. The novel delivery of this program, through distance treatment modalities (e-mail and internet) will allow us to overcome many of the known barriers to treatment so that teachers will receive the necessary information in a timely and efficient manner. The specific research questions that will be addressed are:

1. Does the overall impairment of children with ADHD in the treatment group improve compared to those who are in the waitlist group?

2. Is the school-based intervention effective in reducing ADHD symptoms, improving behavioral functioning, and enhancing academic performance in the active treatment group compared to the waitlist group?

3. Do teachers in the treatment group develop more knowledge about ADHD and more positive and realistic attitudes about this disorder over the course of the intervention?

4. Is the intervention viewed as accessible to teachers and is there evidence of fidelity to the program?

The investigators expect that the program will reduce overall impairment, improve ADHD symptoms, behavioural, and academic functioning in the children and will enhance knowledge and reduce misconceptions of ADHD in teachers. If successful, this program will be disseminated to school boards in Nova Scotia and across Canada, and as such would have the potential to have a significant positive effect on the health and well-being of many children, teachers and parents. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Hyperkinesis

NCT number NCT01547702
Study type Interventional
Source Dalhousie University
Contact
Status Completed
Phase Phase 2
Start date February 2012
Completion date May 2013

See also
  Status Clinical Trial Phase
Completed NCT03260205 - Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) Phase 3
Withdrawn NCT03546400 - Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. Phase 4
Completed NCT02917109 - LearningRx Cognitive Training for ADHD N/A
Completed NCT02248948 - Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children N/A
Recruiting NCT01750307 - The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment) N/A
Recruiting NCT06170996 - Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00735371 - Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 3
Withdrawn NCT03580005 - A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. Phase 4
Completed NCT02578030 - Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD Phase 1
Completed NCT02574273 - Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) N/A
Completed NCT02257216 - Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) N/A
Recruiting NCT04943796 - A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
Recruiting NCT04634006 - Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study N/A
Active, not recruiting NCT02908802 - Probiotic Supplement as Treatment for Students With ADHD N/A
Completed NCT02604407 - Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Phase 3
Completed NCT05870605 - Drug Use Study With Intuniv® in European Countries
Terminated NCT03481959 - Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity Phase 3
Terminated NCT03638466 - Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder Phase 2
Completed NCT03709940 - Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02795637 - Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction Phase 1